The store will not work correctly when cookies are disabled.
N-[4-(Diethylamino)phenyl]-3-methyl-5-(4-methyl-1,2,3-thiadiazol-5-yl)isoxazole-4-carboxamide
ID: ALA4584664
PubChem CID: 155561864
Max Phase: Preclinical
Molecular Formula: C18H21N5O2S
Molecular Weight: 371.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)c1ccc(NC(=O)c2c(C)noc2-c2snnc2C)cc1
Standard InChI: InChI=1S/C18H21N5O2S/c1-5-23(6-2)14-9-7-13(8-10-14)19-18(24)15-11(3)21-25-16(15)17-12(4)20-22-26-17/h7-10H,5-6H2,1-4H3,(H,19,24)
Standard InChI Key: TXSINWFEQCCLEF-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
3.2425 -11.1346 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2364 -11.9518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0112 -12.2120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4983 -11.5527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0211 -10.8903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2779 -10.1120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0568 -9.8649 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.0626 -9.0477 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2872 -8.7897 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8023 -9.4475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9851 -9.4475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3155 -11.5576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7198 -12.2677 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5370 -12.2726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9390 -12.9818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7554 -12.9870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1691 -12.2812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7603 -11.5687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9452 -11.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9862 -12.2851 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3915 -12.9947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2087 -12.9985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3981 -11.5793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2153 -11.5831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7283 -10.8523 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2568 -12.9914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 6 2 0
10 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
21 22 1 0
20 23 1 0
23 24 1 0
12 25 2 0
3 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 371.47 | Molecular Weight (Monoisotopic): 371.1416 | AlogP: 3.91 | #Rotatable Bonds: 6 |
Polar Surface Area: 84.15 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.58 | CX Basic pKa: 5.42 | CX LogP: 2.67 | CX LogD: 2.66 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.71 | Np Likeness Score: -2.10 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |